- PhaseBio Pharmaceuticals (NASDAQ:PHAS): Q3 GAAP EPS of -$0.66 misses by $0.05.
- Revenue of $0.34M misses by $0.73M.
- Press Release
PhaseBio Pharmaceuticals EPS misses by $0.05, misses on revenue
Recommended For You
About PHASQ Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PHASQ | - | - |
PhaseBio Pharmaceuticals, Inc. |